News

Here's an open invitation to steal. It goes out to cancer fighters and tempts them with a new program that predicts cancer drug effectiveness via machine learning and raw genetic data.

The identification of 335 reindeer-specific genes is likely to aid in understanding the special biological characteristics of this iconic species.

Hayden Jeffreys joins CEGX as Chief Operating Officer and Dr Joanne Mason as VP of Biomarker Discovery.

Studies show that women in particular seem to have a harder time quitting, even with assistance, when compared to men. Now, using high-throughput sequencing and gas chromatography–mass spectrometry, scientists report that the difference in gender smoking patterns and smoking's effects could be due to how nicotine impacts the brain-gut relationship.

Scottish Equity Partners (SEP) completes a significant investment in Dotmatics.

Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.

Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world’s deadliest diseases, which affects up to 2 billion people.

Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo.

A new statistical model has enabled researchers to pinpoint 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumours across 12 human cancer types.

According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, rendering the flu vaccine less effective in humans.